- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12:46 | GSK sells liver disease drug candidate to Alfasigma for $690m | ||
| 12:46 | Vinay Prasad to leave the FDA again | ||
| 11:46 | Sciwind secures China's NMPA approval for Ecnoglutide injection | ||
| 11:46 | BMS gains FDA approval for Sotyktu in psoriatic arthritis treatment | ||
| Fr | Alnylam and Tenaya sign $1.23bn cardiovascular target discovery deal | ||
| Fr | J&J announces Tecvayli-Darzalex combo approval from FDA for multiple myeloma | ||
| Fr | Liberate Bio gains licences for myeloid-specific CAR design patents | ||
| Do | Moderna pays up to $2.25bn to settle drug delivery tech patent lawsuit | ||
| Do | CordenPharma leases space at Flatiron Park for peptides development | ||
| Do | Pharmaceutical Technology's parent company GlobalData moves to Main Market of LSE | ||
| Do | Affinia receives FDA fast track designation for AFTX-201 | ||
| Mi | Sanofi bets on Sino Biopharm's transplant drug in $1.5bn licensing deal | ||
| Mi | Aspire Biopharma and Microsize collaborate for alprazolam powder formulation | ||
| Mi | Esperion to acquire Corstasis for cardiovascular franchise expansion | ||
| Di | OSE narrows pipeline focus amid Boehringer MASH collaboration retreat | ||
| Di | Pharma rings the changes as CEO shake-up continues | ||
| Di | Rallybio to acquire Candid Therapeutics | ||
| Di | Novo Nordisk starts €432m Ireland facility upgrade for oral Wegovy production | ||
| Di | Kairos Pharma signs deal for Celyn Therapeutics' CL-273 | ||
| 02.03. | Moderna's dual Covid-flu vaccine poised for EMA approval on positive CHMP take | ||
| 02.03. | Sanofi receives CHMP recommendation for Dupixent expansion in Europe | ||
| 02.03. | FDA approves Ascendis Pharma's weekly Yuviwel for paediatric dwarfism | ||
| 02.03. | Sanofi receives CHMP recommendation for Dupixent approval in Europe | ||
| 02.03. | BioMarin receives FDA approval for Palynziq use in adolescents | ||
| 27.02. | Boehringer inks $500m Sitryx deal, secures CPNV-driven Hernexeos approval |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.